Dalent Medical

Dalent Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Dalent Medical is a private, commercial-stage medical device company targeting the expansive ENT market with a platform of diagnostic and therapeutic tools. Its flagship product, the Sinusleeve® Balloon, is FDA-listed and commercially available, positioned as a lower-cost, versatile alternative in the balloon sinus dilation segment. The company is developing a complementary pipeline including the Tracker™ balloon for Eustachian tube dysfunction and a diagnostic ultrasound, aiming to address a holistic $10B+ market opportunity. Founded by an ENT surgeon and an engineer, Dalent has secured initial funding, built strong IP, and is led by a team with significant medical device commercialization and exit experience.

Otolaryngology (ENT)Chronic SinusitisEustachian Tube Dysfunction

Technology Platform

A platform for minimally invasive ENT procedures centered on a patented, low-cost conforming balloon sleeve (Sinusleeve®) that fits over reusable cannulas, enabling simultaneous suction and dilation. The platform is expanding to include a novel atraumatic everting balloon for Eustachian tubes and a complementary diagnostic ultrasound technology.

Opportunities

Dalent operates in a large ($10B+) and growing ENT market, with a specific opportunity to capture share in the balloon sinus dilation segment by offering a cost-effective, versatile alternative.
The larger, untapped opportunity lies in addressing Eustachian Tube Dysfunction (ETD) with a combined diagnostic and therapeutic solution, creating a new standard of care in an area with high unmet need.

Risk Factors

Key risks include intense competition from large, established medical device companies in the sinus dilation space, execution risks associated with developing and commercializing its pipeline ETD products, and the financial risk inherent in a small, private company scaling its operations and sales force.

Competitive Landscape

In balloon sinus dilation, Dalent faces well-funded giants like Johnson & Johnson (Acclarent), Stryker, and Medtronic. Its competitive edge is a lower-cost, reusable-friendly platform. In the emerging ETD space, competition includes other specialized device developers, and Dalent's potential advantage is a first-in-class atraumatic balloon coupled with a diagnostic tool.